Effects of Ipragliflozin on Postprandial Glucose Metabolism and Gut Peptides in Type 2 Diabetes: A Pilot Study.

about

Effects of Ipragliflozin on Postprandial Glucose Metabolism and Gut Peptides in Type 2 Diabetes: A Pilot Study.

Item

http://www.wikidata.org/entity/Q48264817

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Effects of Ipragliflozin on Po ...... ype 2 Diabetes: A Pilot Study.

@en

Effects of Ipragliflozin on Po ...... ype 2 Diabetes: A Pilot Study.

@nl

type

Item

label

Effects of Ipragliflozin on Po ...... ype 2 Diabetes: A Pilot Study.

@en

Effects of Ipragliflozin on Po ...... ype 2 Diabetes: A Pilot Study.

@nl

prefLabel

Effects of Ipragliflozin on Po ...... ype 2 Diabetes: A Pilot Study.

@en

Effects of Ipragliflozin on Po ...... ype 2 Diabetes: A Pilot Study.

@nl

P1476

Effects of Ipragliflozin on Po ...... Type 2 Diabetes: A Pilot Study

@en

P2093

Emi Ebihara

http://www.w3.org/2001/XMLSchema#string

Hideyuki Sakoda

http://www.w3.org/2001/XMLSchema#string

Hiroko Nakazato

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Nagamine

http://www.w3.org/2001/XMLSchema#string

Kenji Noma

http://www.w3.org/2001/XMLSchema#string

Masamitsu Nakazato

http://www.w3.org/2001/XMLSchema#string

Takahisa Kawano

http://www.w3.org/2001/XMLSchema#string

P2860

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology.

Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition.

Changes in Levels of Biomarkers Associated with Adipocyte Function and Insulin and Glucagon Kinetics During Treatment with Dapagliflozin Among Obese Type 2 Diabetes Mellitus Patients.

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.

SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.

Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis.

Beneficial effects of sodium-glucose cotransporter 2 inhibitors for preservation of pancreatic β-cell function and reduction of insulin resistance.

Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus.

Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes

P2888

s13300-018-0366-8

P304

403-411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1007/S13300-018-0366-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hiroaki Ueno

P577

2018-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29322485

http://www.w3.org/2001/XMLSchema#string

P932

5801252

http://www.w3.org/2001/XMLSchema#string